Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients with dyslipidemia
• Patient with diagnosis of clinical atherosclerotic cardiovascular disease (acute coronary syndrome, history of myocardial infarction, stable or unstable angina, history of coronary artery reperfusion, stroke or transient stroke, history of peripheral arterial disease or peripheral arterial reperfusion)
• Patients with metabolic syndrome but without diabetes
Locations
Other Locations
Republic of Korea
Yonsei University Health System, Severance Hospital
RECRUITING
Seoul
Contact Information
Primary
Byeong-Keuk Kim
KIMBK@yuhs.ac
82-2-2228-8465
Time Frame
Start Date: 2023-06-13
Estimated Completion Date: 2027-06-01
Participants
Target number of participants: 250
Treatments
Experimental: Group P
Pitavastatin 4mg group
Experimental: Group PE
Pitavastatin 4 mg Ezetimibe 10 mg combined administration group
Active_comparator: Group A
Atorvastatin 40 mg administration group
Related Therapeutic Areas
Sponsors
Leads: Yonsei University